Advertisement

Topics

Prospect Medical Holdings, Inc. Company Profile

08:55 EST 20th November 2017 | BioPortfolio

PROS (NYSE: PRO) is the leading provider of profitability management and optimization software, enabling companies to unlock the value hidden in their data to improve financial performance. Through a combination of business knowledge and science enabled software, PROS software manages and optimizes all of the financial levers that impact a company’s profitability. As a result, PROS customers have realized hundreds of millions in sustained bottom-line profitability improvement. Founded in 1985, PROS has implemented more profitability management and optimization solutions than any other market provider. To learn more about PROS, please visit www.prospricing.com.


News Articles [513 Associated News Articles listed on BioPortfolio]

Integer Holdings: What you need to know

Greatbatch and Lake Region Medical merged nearly two years ago to become Integer Holdings, a giant medical device contract ma -More- 

Comparing Parnell Pharmaceuticals Holdings

Parnell Pharmaceuticals Holdings and Mylan N.V. are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst reco...

Otsuka Holdings' medtech business to be transferred to medical device unit

Otsuka Holdings said it intends to move its medical device business to Otsuka Medical Devices, its wholly owned unit, effecti -More- 

‘You Could Do It Tomorrow’: How Soon Is ‘Soon’ for Trans Women Wanting to Give Birth?

(Sacramento Bee) – Medical treatments for transgender people have gone “mainstream,” according to Richard Paulson, an obstetrician-gynecologist in Los Angeles and the president of the Americ...

Analyzing Parnell Pharmaceuticals Holdings

Parnell Pharmaceuticals Holdings and Mylan are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitabiliy, dividends, ...

Destiny Pharma partners with China Medical System Holdings

Destiny Pharma licensed China Medical System Holdings Ltd. rights to develop and commercialize its anti-infective assets in China and certain other Asian countries with the exception of Japan.

AgaMatrix secures $32M loan from Prospect Capital

Prospect Capital provided AgaMatrix loan financing worth $32 million in support of the AgaMatrix's reorganization into two se -More- 

Medical News Today: How to deal with becoming a new parent

The prospect of becoming a parent can be overwhelming. In this Spotlight feature, we give some basic but vital tips to help you to weather the storm.

PubMed Articles [1808 Associated PubMed Articles listed on BioPortfolio]

Prospects of molecular breeding in medical plants.

The molecular-assisted breeding, transgenic breeding and molecular designing breeding are three development directions of plant molecular breeding. Base on these three development directions, this pap...

Pig movements in France: Designing network models fitting the transmission route of pathogens.

Pathogen spread between farms results from interaction between the epidemiological characteristics of infectious agents, such as transmission route, and the contact structure between holdings. The obj...

Nurturing virtues of the medical profession: does it enhance medical students' empathy?

To examine if the empathy levels of first-year medical students are amenable to didactic interventions idealized to promote values inherent to medical professional identity.

The prospect of untreatable gonorrhoea.

The MD-MEd Joint-Degree Program at Vanderbilt University: Training Future Expert Medical Educators.

Some medical students are drawn to medical education as an area of academic specialization. However, few options exist for medical students who wish to build a scholarly foundation for future careers ...

Clinical Trials [1443 Associated Clinical Trials listed on BioPortfolio]

PROSPECT: An Imaging Study in Patients With Unstable Atherosclerotic Lesions

PROSPECT is a multi-center prospective registry of Acute Coronary Syndromes (ACS) patients with single or double vessel coronary artery disease. Approximately 700 patients with ACS will be...

PROSPECT-C: A Study of Biomarkers of Response or Resistance to Anti-EGFR Therapies in Metastatic Colorectal Cancer

PROSPECT-C is a phase II study investigating the molecular markers of response or resistance to anti-epidermal growth factor receptor (EGFR) antibodies.

PROSPECT: Predictors of Response to Cardiac Re-Synchronization Therapy

Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes. Using a medical ...

Extended-Release Naltrexone for Alcohol Dependence in Primary Care

Naltrexone is an opioid antagonist with a high affinity for the mu opioid receptor. The efficacy of extended-release naltrexone (Vivitrol) as a treatment for alcohol dependence has been d...

Prospective Study Evaluating the Use of PROSPECT to Reduce Insomnia in Patients With Early Stage Breast Cancer

Women with early stage breast cancer may experience difficulty falling asleep or staying asleep. If this occurs for more than 4 weeks, these participants may have chronic insomnia. Chronic...

Companies [1573 Associated Companies listed on BioPortfolio]

Prospect Medical Holdings, Inc.

PROS (NYSE: PRO) is the leading provider of profitability management and optimization software, enabling companies to unlock the value hidden in their data to improve financial pe...

Prospect Partners, LLC

Prospect Partners is a leading private equity firm investing in smaller lower-middle-market companies, managing $470 million across three funds. A highly experienced and active in...

The American Prospect

The American Prospect was founded in 1990 as an authoritative magazine of liberal ideas, committed to a just society, an enriched democracy, and effective liberal politics. Robert Kuttner, Robert Reic...

Christie Medical Holdings Inc.

Christie Medical Holdings Inc. is a global company based in Memphis, Tenn., that discovers, develops and commercializes medical technologies. The company’s market-leading pro...

WealthEngine

WealthEngine is a leading provider of sophisticated prospect research and analytics to nonprofit organizations and institutions of higher education, financial services firms, and other for profit orga...

More Information about "Prospect Medical Holdings, Inc." on BioPortfolio

We have published hundreds of Prospect Medical Holdings, Inc. news stories on BioPortfolio along with dozens of Prospect Medical Holdings, Inc. Clinical Trials and PubMed Articles about Prospect Medical Holdings, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prospect Medical Holdings, Inc. Companies in our database. You can also find out about relevant Prospect Medical Holdings, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record